Annexon Inc (ANNX)
5.155
+0.16
(+3.31%)
USD |
NASDAQ |
Dec 04, 16:00
5.155
0.00 (0.00%)
After-Hours: 20:00
Annexon Enterprise Value: 191.79M for Dec. 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| December 03, 2024 | 191.79M |
| December 02, 2024 | 221.63M |
| November 29, 2024 | 234.42M |
| November 27, 2024 | 229.09M |
| November 26, 2024 | 223.76M |
| November 25, 2024 | 203.51M |
| November 22, 2024 | 207.77M |
| November 21, 2024 | 210.97M |
| November 20, 2024 | 209.91M |
| November 19, 2024 | 241.88M |
| November 18, 2024 | 241.88M |
| November 15, 2024 | 312.24M |
| November 14, 2024 | 334.62M |
| November 13, 2024 | 358.07M |
| November 12, 2024 | 364.47M |
| November 11, 2024 | 402.84M |
| November 08, 2024 | 424.17M |
| November 07, 2024 | 437.91M |
| November 06, 2024 | 449.54M |
| November 05, 2024 | 426.28M |
| November 04, 2024 | 409.37M |
| November 01, 2024 | 429.46M |
| October 31, 2024 | 433.68M |
| October 30, 2024 | 456.94M |
| October 29, 2024 | 460.11M |
| Date | Value |
|---|---|
| October 28, 2024 | 460.11M |
| October 25, 2024 | 442.14M |
| October 24, 2024 | 446.37M |
| October 23, 2024 | 435.80M |
| October 22, 2024 | 460.11M |
| October 21, 2024 | 450.60M |
| October 18, 2024 | 450.60M |
| October 17, 2024 | 466.45M |
| October 16, 2024 | 465.40M |
| October 15, 2024 | 447.43M |
| October 14, 2024 | 443.20M |
| October 11, 2024 | 440.03M |
| October 10, 2024 | 401.97M |
| October 09, 2024 | 394.57M |
| October 08, 2024 | 388.23M |
| October 07, 2024 | 308.95M |
| October 04, 2024 | 324.80M |
| October 03, 2024 | 316.34M |
| October 02, 2024 | 338.54M |
| October 01, 2024 | 305.77M |
| September 30, 2024 | 285.69M |
| September 27, 2024 | 280.02M |
| September 26, 2024 | 277.90M |
| September 25, 2024 | 278.96M |
| September 24, 2024 | 296.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-135.12M
Minimum
Mar 30 2022
1.202B
Maximum
Aug 12 2020
245.19M
Average
163.42M
Median
Apr 26 2024
Enterprise Value Benchmarks
| CEL-SCI Corp | 36.94M |
| AIM ImmunoTech Inc | 8.660M |
| IGC Pharma Inc | 26.16M |
| NovaBay Pharmaceuticals Inc | 2.076M |
| Protalix BioTherapeutics Inc | 93.35M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -34.82M |
| Total Expenses (Quarterly) | 39.44M |
| EPS Diluted (Quarterly) | -0.25 |
| Earnings Yield | -20.17% |